Amino acid biology is fundamental to life, regulating biological pathways critical to health.  A variety of conditions occur when amino acid pathways become dysregulated. Pronutria Biosciences is a clinical-stage biotechnology company developing first-in-class solutions to these conditions with a focus on amino acid biology.  Using insights from a clinically validated body of evidence, we are pioneering new nutritional and therapeutic modalities: amino acid biologics. This novel approach allows us to precisely target biology that was previously inaccessible, providing a unique opportunity to address a variety of serious diseases and medical conditions using nutritional and therapeutic approaches. 
We are innovating at the frontier of amino acid biology. We have generated a library of over 1 billion protein sequences and have developed the proprietary tools to identify disease specific product candidates.  We have assembled a world-class team of industry leaders, united by their commitment to profoundly improve the lives of patients and families. Together, we are singularly focused on developing solutions for patients and families with few or no alternatives including those with muscle, metabolic, neurological, liver disorders and inborn errors of metabolism. 

"I am excited to lead the group of world-class scientists at Pronutria Biosciences using regenerative therapeutics to improve the lives of patients and their families."
- Peter Mueller, President of R&D, and Chief Scientific Officer